What Ifopa Isn T Clearing Up The Confusion To Create Better Care
Received 2021 Aug 5; Accepted 2022 Feb 6; Collection date 2022. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to... The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from... To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, disabling genetic disorder characterized by congenital malformations of the great toes and progressive heterotopic ossification of soft and connective tissues. Assiduous attention to the unmet needs of this patient community is crucial to prevent potential iatrogenic harm and optimize care for individuals with FOP. To gather international expert opinion and real-world experience on the key challenges for individuals with FOP and their families, highlight critical gaps in care, communication, and research, and provide recommendations for improvement. An international group of expert clinicians, patients and patient advocates, caregivers and representatives from the international FOP community participated in a virtual, half-day meeting on 22 March 2021 to discuss the key unmet needs... By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers.
Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence. By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […] I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult.
During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my... Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements. Determined for answers, we asked for full exome sequencing to be performed.
After an agonizing few months wait, we finally received a diagnosis in June 2023 – “PPA2 Mutation – Sudden Cardiac Failure”. Upon frantically searching the internet, we found that it was not only rare, but that the outcome was bleak. PPA2 Deficiency is an autosomal recessive mitochondrial disease that affects the energy production in the body. At the time of diagnosis, literature reported that there were 65 known cases with only 10 living individuals worldwide. There is no treatment or cure currently available for PPA2. In an effort to find more information, we came across a Facebook group for PPA2 that consisted of approximately 20 members from all around the world whom had family members affected.
Today our group has close to 80 members, with 20 being individuals affected by PPA2 that are still alive. Accelerate Discovery with the World’s leading Science, Technology and Innovation Marketplace Connect with the world’s biggest companies, everyday Share your expertise and experience with global businesses and charities to accelerate innovation impact Answers to common questions about the Innocentive It’s our mission to change the world, one idea at a time.
We would love you to join us. Many people still misunderstand Fibrodysplasia Ossificans Progressiva (FOP). Some believe it’s a form of arthritis or the result of injury. Others confuse its symptoms with tumors or infections. These misconceptions lead to dangerous decisions, including unnecessary surgeries and misdiagnoses. FOP is not caused by trauma.
It is a genetic condition rooted in a mutation of the ACVR1 gene. This mutation triggers abnormal bone growth in muscles and connective tissues—often without any clear external cause. In many cases, even gentle physical therapy or a minor fall can lead to a flare-up. Because early signs of FOP mimic other conditions, many children face incorrect treatments. Biopsies and surgeries often make things worse. That’s why educating first-line responders—doctors, dentists, physiotherapists—is essential.
Organizations like FOP Trust India and IFOPA are filling this gap. They run educational campaigns in schools, hospitals, and public health forums. They also distribute emergency kits and diagnostic guides to help professionals make accurate, life-saving choices. With research ongoing and new treatment pathways emerging, awareness is more important than ever. Clear understanding leads to early diagnosis. Early diagnosis prevents harm.
And prevention gives children with FOP a chance at a safer, more supported life. 1520 Clay St, Ste H2, North Kansas City, MO 64116North Kansas City, Missouri, United States The International Fibrodysplasia Ossificans Progressiva Association (IFOPA) is a voluntary, non-profit organization that supports those afflicted by the rare genetic condition Fibrodysplasia Ossificans Progressiva and their families by instilling hope worldwide while searching for... Their mission is to eliminate FOP as a health concern through education, research, advocacy, and support. Fibrodysplasia ossificans progressiva (FOP) is a very rare inherited connective tissue disorder characterized by the abnormal development of bone in areas of the body where bone is not normally present (heterotopic ossification), such as...
People Also Search
- What IFOPA Isn't: Clearing Up the Confusion to Create Better Care
- IFOPA - International Fibrodysplasia Ossificans Progressiva Association
- Current challenges and opportunities in the care of patients with ...
- Sharing Fibrodysplasia Ossificans Progressiva Stories During Global FOP ...
- International Fibrodysplasia Ossificans Progressiva Association
- What FOP Isn't: Clearing Up the Confusion to Create Better Care
- Bridging the gap between pediatric and adult care - IFOPA ...
- International FOP Association (IFOPA) - National Organization for Rare ...
- Int'l Fibrodysplasia Ossificans Progressiva Assoc - YouTube
- Care Considerations and Treatment Guidelines - IFOPA - International ...
Received 2021 Aug 5; Accepted 2022 Feb 6; Collection Date
Received 2021 Aug 5; Accepted 2022 Feb 6; Collection date 2022. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to... The images or other third party material in this article are included in the article's Creative ...
Fibrodysplasia Ossificans Progressiva (FOP) Is An Ultra-rare, Disabling Genetic Disorder
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, disabling genetic disorder characterized by congenital malformations of the great toes and progressive heterotopic ossification of soft and connective tissues. Assiduous attention to the unmet needs of this patient community is crucial to prevent potential iatrogenic harm and optimize care for individuals with FOP. To gather internation...
Early Concerns Were Minimized, And Our Pleas For Help Were
Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence. By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […] I was competitive tennis pla...
During This Entire Young Adult Experience, My Doctors Would Tell
During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my... Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These...
After An Agonizing Few Months Wait, We Finally Received A
After an agonizing few months wait, we finally received a diagnosis in June 2023 – “PPA2 Mutation – Sudden Cardiac Failure”. Upon frantically searching the internet, we found that it was not only rare, but that the outcome was bleak. PPA2 Deficiency is an autosomal recessive mitochondrial disease that affects the energy production in the body. At the time of diagnosis, literature reported that the...